Substance
IPILIMUMAB
Global reference: every product and company linked to this substance.
- cas: 477202-00-9
- ncit: C2654
- rxnorm: 1094833
- unii: 6T8C155666
BMS-734016 · BMS734016 · ipilimumab [INN] · IPILIMUMAB [JAN] · IPILIMUMAB [USAN] · Ipilimumab [WHO-DD] · MDX-010 · MDX-101 · MDX-CTLA-4 · MDX010 · YERVOY
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK | YERVOY | Q2 2026 | $769.0M |
| BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK | YERVOY | Q2 2026 | $769.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- YERVOY · BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK
- YERVOY · BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK